Evidence map›Paper›PMID 22105693›Full record

ArticleStatistics in medicine2011

Integrative analysis of multiple cancer prognosis studies with gene expression measurements.

Shuangge Ma, Jian Huang, Fengrong Wei, Yang Xie, Kuangnan Fang

Abstract read
In one paragraph

Article in Statistics in medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Integrative Analysis of Cancer Diagnosis Studies with Composite Penalization.Scandinavian journal of statistics, theory and applications · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuangge MaSchool of Public Health, Yale University, New Haven, CT, USA. shuangge.ma@yale.edu
Jian Huang
Fengrong Wei
Yang Xie
Kuangnan Fang

Funding

Predicting Adjuvant Chemotherapy Response in Lung CancerR01CA152301 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2010 to 2014
$1.5M
Novel Methods for Integrative Analysis of Cancer Genomic DataR01CA142774 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE · 2010 to 2013
$1.3M
Regularized Classification & Survival Analysis for Expression Profiling of CancerR01CA120988 · NCI · UNIVERSITY OF IOWA · PI HUANG, JIAN · 2008 to 2011
$1.2M
Efficient microarray meta analysis and cancer biomarker selectionR03LM009828 · NLM · YALE UNIVERSITY · PI MA, SHUANGGE · 2008 to 2009
$175k
NCI NIH HHS CA120988NCI NIH HHS CA142774NCI NIH HHS CA152301NCI NIH HHS R01 CA120988NCI NIH HHS R01 CA142774NCI NIH HHS R01 CA152301NLM NIH HHS LM009828NLM NIH HHS R03 LM009828
6 · The paper itself

Abstract

Although in cancer research microarray gene profiling studies have been successful in identifying genetic variants predisposing to the development and progression of cancer, the identified markers from analysis of single datasets often suffer low reproducibility. Among multiple possible causes, the most important one is the small sample size hence the lack of power of single studies. Integrative analysis jointly considers multiple heterogeneous studies, has a significantly larger sample size, and can improve reproducibility. In this article, we focus on cancer prognosis studies, where the response variables are progression-free, overall, or other types of survival. A group minimax concave penalty (GMCP) penalized integrative analysis approach is proposed for analyzing multiple heterogeneous cancer prognosis studies with microarray gene expression measurements. An efficient group coordinate descent algorithm is developed. The GMCP can automatically accommodate the heterogeneity across multiple datasets, and the identified markers have consistent effects across multiple studies. Simulation studies show that the GMCP provides significantly improved selection results as compared with the existing meta-analysis approaches, intensity approaches, and group Lasso penalized integrative analysis. We apply the GMCP to four microarray studies and identify genes associated with the prognosis of breast cancer.

Indexed as

Gene Expression ProfilingModels, StatisticalAlgorithmsBreast NeoplasmsComputer SimulationFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateLeast-Squares AnalysisMeta-Analysis as TopicNeoplasmsOligonucleotide Array Sequence AnalysisPrognosisSample SizeSurvival Analysis

Identifiers

PMID22105693
PMCPMC3399910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.